Barriers to Adverse Drug Reaction Reporting Among Physicians, Nurses, and Pharmacists: A Scoping Review Comparing High-Income Versus Low-/Middle-Income Countries.
Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Azfar Athar IshaquiDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62583, Saudi Arabia.ORCID 0000-0003-0688-2625
Rina TripathiDepartment of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al Hofuf 31982, Saudi Arabia.
Pushp Lata RajpootDepartment of Public Health, College of Nursing and Health Sciences, Jazan University, Jazan 45142, Saudi Arabia.ORCID 0000-0002-2444-7996
Reham BakhshDepartment of Public Health, College of Nursing and Health Sciences, Jazan University, Jazan 45142, Saudi Arabia.
Hemalatha ThanganadarDepartment of Public Health, College of Nursing and Health Sciences, Jazan University, Jazan 45142, Saudi Arabia.
Muath Ahmed AldominiDepartment of Health Promotion and Education, College of Public Health and Health Informatics, Umm Al Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0002-1048-6847
Salman Ashfaq AhmadFaculty of Pharmacy, Iqra University, Karachi 75850, Pakistan.
Khalid OrayjDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62583, Saudi Arabia.ORCID 0000-0001-6651-2306
Narendar KumarDepartment of Pharmacy Practice, Faculty of Pharmacy, University of Sindh, Jamshoro 76080, Pakistan.ORCID 0000-0002-2648-3915
Asaad Ahmed Asaad KhalilQuality and Performance Administration, Eastern Health Cluster, Ministry of Health, Dammam 32253, Saudi Arabia.
Mohammed Ali KaddouraClinical Excellence Administration, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia.
Muhammad Bilal MaqsoodQuality and Performance Administration, Eastern Health Cluster, Health Holding Company, Dammam 32253, Saudi Arabia.ORCID 0000-0003-1358-0350
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
adverse drug reactionshigh-income countrieslow-income countriesnursespharmacistspharmacovigilancephysicians
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Barriers to Adverse Drug Reaction Reporting Among Physicians, Nurses, and Pharmacists: A Scoping Review Comparing High-Income Versus Low-/Middle-Income Countries. · full record | OpenQuestion